233 related articles for article (PubMed ID: 33627484)
21. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
[TBL] [Abstract][Full Text] [Related]
22. Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons.
Albers KM; Zhang XL; Diges CM; Schwartz ES; Yang CI; Davis BM; Gold MS
Mol Pain; 2014 May; 10():31. PubMed ID: 24886596
[TBL] [Abstract][Full Text] [Related]
23. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
24. Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy.
Buchwald ZS; Nasti TH; Lee J; Eberhardt CS; Wieland A; Im SJ; Lawson D; Curran W; Ahmed R; Khan MK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028691
[TBL] [Abstract][Full Text] [Related]
25. PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Tumeh PC; Harview CL; Yearley JH; Shintaku IP; Taylor EJ; Robert L; Chmielowski B; Spasic M; Henry G; Ciobanu V; West AN; Carmona M; Kivork C; Seja E; Cherry G; Gutierrez AJ; Grogan TR; Mateus C; Tomasic G; Glaspy JA; Emerson RO; Robins H; Pierce RH; Elashoff DA; Robert C; Ribas A
Nature; 2014 Nov; 515(7528):568-71. PubMed ID: 25428505
[TBL] [Abstract][Full Text] [Related]
26. Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma.
Pilon-Thomas S; Mackay A; Vohra N; Mulé JJ
J Immunol; 2010 Apr; 184(7):3442-9. PubMed ID: 20194714
[TBL] [Abstract][Full Text] [Related]
27. Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells.
Hezam K; Jiang J; Sun F; Zhang X; Zhang J
Rev Neurosci; 2018 Jan; 29(1):93-98. PubMed ID: 28937965
[TBL] [Abstract][Full Text] [Related]
28. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
[TBL] [Abstract][Full Text] [Related]
29. miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma.
Li S; Li Z; Guo F; Qin X; Liu B; Lei Z; Song Z; Sun L; Zhang HT; You J; Zhou Q
J Biomed Sci; 2011 Mar; 18(1):24. PubMed ID: 21453483
[TBL] [Abstract][Full Text] [Related]
30. Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer.
Gong X; Li X; Jiang T; Xie H; Zhu Z; Zhou F; Zhou C
J Thorac Oncol; 2017 Jul; 12(7):1085-1097. PubMed ID: 28478231
[TBL] [Abstract][Full Text] [Related]
31. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
[TBL] [Abstract][Full Text] [Related]
32. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
33. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
34. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells.
Pandey V; Qian PX; Kang J; Perry JK; Mitchell MD; Yin Z; Wu ZS; Liu DX; Zhu T; Lobie PE
Endocrinology; 2010 Mar; 151(3):909-20. PubMed ID: 20118197
[TBL] [Abstract][Full Text] [Related]
35. Artemin has potent neurotrophic actions on injured C-fibres.
Bennett DL; Boucher TJ; Michael GJ; Popat RJ; Malcangio M; Averill SA; Poulsen KT; Priestley JV; Shelton DL; McMahon SB
J Peripher Nerv Syst; 2006 Dec; 11(4):330-45. PubMed ID: 17117942
[TBL] [Abstract][Full Text] [Related]
36. Radiation Therapy Plus Anti-Programmed Death Ligand 1 Immunotherapy: A Review on Overall Survival.
Krcik EM
Radiol Technol; 2016 Sep; 88(1):123-8. PubMed ID: 27601709
[TBL] [Abstract][Full Text] [Related]
37. PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED
Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325
[TBL] [Abstract][Full Text] [Related]
38. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
[TBL] [Abstract][Full Text] [Related]
39. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.
Kang J; Qian PX; Pandey V; Perry JK; Miller LD; Liu ET; Zhu T; Liu DX; Lobie PE
Oncogene; 2010 Jun; 29(22):3228-40. PubMed ID: 20305694
[TBL] [Abstract][Full Text] [Related]
40. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
